Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Powell Michael
Relationship:   10% Owner
City:   San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   21    
Direct Shares   22,645,475    

Indirect Shares

   6,181,468      
Direct Value   $17,584,142    

Indirect Value

   $148,315,620      
Total Shares   28,826,943      
Total Value   $165,899,762      


Seagen Inc $4,575,029 Molecular Templates, Inc. $2,064,809 Anesiva Inc $0 Paratek Pharmaceuticals Inc $96,365 Humanigen Inc $41 Aravive Inc $86,094 Aclaris Therapeutics, Inc. $2,701,586 Entasis Therapeutics Holdings Inc. $2,584,590 Nextcure, Inc. $0 Iterum Therapeutics Plc $1,839,771 Akouos, Inc. $0 Inozyme Pharma, Inc. $0 Bolt Biotherapeutics, Inc. $3,635,857 Vera Therapeutics, Inc. $0 Seagen Inc $4,575,029 Molecular Templates, Inc. $2,064,809 Anesiva Inc $0 Paratek Pharmaceuticals Inc $96,365 Humanigen Inc $41 Aravive Inc $86,094 Aclaris Therapeutics, Inc. $2,701,586 Entasis Therapeutics Holdings Inc. $2,584,590 Nextcure, Inc. $0 Iterum Therapeutics Plc $1,839,771 Akouos, Inc. $0 Inozyme Pharma, Inc. $0 Bolt Biotherapeutics, Inc. $3,635,857 Vera Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    2    

     Stock price went up :
    0   
    2    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   -1.0   
   2.0   
     Percentage Gain/Loss :
   -63.7%
 32.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Seagen Inc SGEN Director 2004-12-16 20,001 2004-12-16 647,577    Premium*  
            Molecular Templates, Inc. MTEM Director 2005-03-08 3,440,201 2006-03-16 12,846    Premium*  
            Anesiva Inc ANSVQ Director, 10% Owner 2007-12-18 65 2007-12-18 4,906,973    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 2006-05-09 43,213 0    Premium*  
            Orexigen Therapeutics, Inc. OREX Director 2010-12-23 1 2010-12-23 0    Premium*  
            Trius Therapeutics Inc TSRX Director 2010-08-06 0 2012-03-26 9,302    Premium*  
            Humanigen Inc HGEN 10% Owner 2013-02-05 414,394 2013-02-05 0    Premium*  
            Ocera Therapeutics Inc OCRX Director 2016-07-29 0 2016-10-31 14,328    Premium*  
            Aravive Inc ARAV 10% Owner 2014-03-26 2,146,978 2014-03-26 0    Premium*  
            Hyperion Therapeutics Inc HPTX 10% Owner 2015-05-07 0 2014-06-04 0    Premium*  
            Aerie Pharmaceuticals Inc AERI 10% Owner 2014-07-10 0 2014-07-09 0    Premium*  
            Marinus Pharmaceuticals Inc MRNS 10% Owner 2014-08-05 0 2016-10-20 15,470    Premium*  
            Synlogic Inc SYBX Director 2015-10-05 0 2018-01-26 574,972    Premium*  
            Aclaris Therapeutics, Inc. ACRS 10% Owner 2015-10-13 2,289,480 2015-10-13 0    Premium*  
            Entasis Therapeutics Holdings Inc. ETTX 10% Owner 2018-09-28 1,180,178 2018-09-28 0    Premium*  
            Nextcure, Inc. NXTC 10% Owner 2019-11-15 2,671,856 2019-11-15 0    Premium*  
            Iterum Therapeutics Plc ITRM 10% Owner 2020-06-02 1,226,514 2020-06-01 0    Premium*  
            Akouos, Inc. AKUS 10% Owner 2020-06-30 1,515,073 2020-06-30 0    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2020-07-28 2,028,308 2020-07-28 0    Premium*  
            Bolt Biotherapeutics, Inc. BOLT 10% Owner 2021-02-09 2,754,437 2021-02-09 0    Premium*  
            Vera Therapeutics, Inc. VERA 10% Owner 2021-05-18 2,914,776 2021-05-18 0    Premium*  
* Premium Members only  

Records found :    126         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ANSVQ Anesiva Inc officerTitle   –       •      –    2005-12-15 3 IO $0.00 $0 D/D 0 64 -
ANSVQ Anesiva Inc officerTitle   –       •      –    2005-12-15 3 IO $0.00 $0 I/I 0 26,249 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2006-05-09 3 IO $0.00 $0 D/D 0 43,213 -
SGEN Seagen Inc Director   –       •      –    2004-09-23 4/A S $0.00 $0 I/I (0) 1,140,101 -
MTEM Molecular Templates, Inc. Director   –       •       •   2005-03-08 4 B $6.27 $6 D/D 1 3,440,201 3.84 -
ANSVQ Anesiva Inc Director   –       •      –    2006-08-15 4 B $6.86 $7 D/D 1 1 2.31 -
ANSVQ Anesiva Inc Director   –       •      –    2006-08-15 4/A B $6.86 $7 D/D 1 65 2.31 -
OREX Orexigen Therapeutics, In... Director   –       •      –    2008-08-29 4 S $12.09 $8,460 I/I (700) 454,748 0 -
SGEN Seagen Inc Director   –       •      –    2004-09-15 4 S $6.70 $6,700 I/I (1,000) 1,284,032 -
SGEN Seagen Inc Director   –       •      –    2004-11-11 4 S $6.70 $16,750 I/I (2,500) 1,079,320 -
TSRX Trius Therapeutics Inc Director   –       •      –    2012-01-19 4 AS $5.64 $14,662 I/I (2,600) 113,100 0 -
SGEN Seagen Inc Director   –       •      –    2003-12-04 4 S $6.45 $20,659 I/I (3,203) 1,937,795 -
TSRX Trius Therapeutics Inc Director   –       •      –    2012-01-18 4 AS $5.56 $23,895 I/I (4,300) 115,700 0 -
OREX Orexigen Therapeutics, In... Director   –       •      –    2008-08-25 4 S $12.00 $57,612 I/I (4,800) 31,555 0 -
OREX Orexigen Therapeutics, In... Director   –       •      –    2008-08-21 4 S $12.00 $63,600 I/I (5,300) 31,655 0 -
SGEN Seagen Inc Director   –       •      –    2004-08-27 4 S $6.75 $37,125 I/I (5,500) 1,310,289 -
SGEN Seagen Inc Director   –       •      –    2003-12-09 4 S $6.90 $41,420 I/I (6,000) 1,883,335 -
SGEN Seagen Inc Director   –       •      –    2004-12-16 4 S $7.00 $45,500 I/I (6,500) 647,577 -
OCRX Ocera Therapeutics Inc Director   –       •      –    2016-09-12 4 S $2.29 $14,926 I/I (6,512) 9,540 0 -
SGEN Seagen Inc Director   –       •      –    2003-12-30 4 S $8.90 $62,300 I/I (7,000) 1,791,677 -
SGEN Seagen Inc Director   –       •      –    2004-11-29 4 S $7.00 $49,160 I/I (7,000) 880,443 -
SGEN Seagen Inc Director   –       •      –    2004-08-19 4 S $6.75 $50,665 I/I (7,500) 1,461,999 -
SGEN Seagen Inc Director   –       •      –    2004-12-06 4 S $7.25 $55,800 I/I (7,500) 724,356 -
AERI Aerie Pharmaceuticals Inc 10% Owner   –       –       •   2014-07-10 4 S $25.81 $207,030 D/D (8,022) 0 0 -
SGEN Seagen Inc Director   –       •      –    2003-12-03 4 S $6.60 $56,100 I/I (8,500) 1,940,910 -
  126  Records found
  1  2   3   4   5   6      
  Page 1 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us